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Phenothiazines are compounds with well known neurolep-
tic activity. Chlorpromazine remains the most widely used
psychotropic drug throughout the world and continues to
serve as a standard by which other neuroleptics are com-
pared.1) Other phenothiazine analogues possess antidepres-
sive rather than neuroleptic action and are widely used for
the treatment of depressive states. Of the various phenothi-
azines, the piperazine derivatives were found to be potent
antiemetics. The increasing need to determine low concentra-
tions of these drugs has led to the development of a number
of methods.
Official methods used for the determination of phenothi-
azines in pharmaceutical preparations are usually based on
extraction as a free base and subsequent determination by
UV-spectrophotometry.2,3) Many organic compounds, drug
excipients and diluents as well as various organic bases,
strongly interfere. Several titrimetric procedures based on the
redox properties of s-atom using hexacyanoferrate(III),4)
sodium metavanadate5) and potassium bromate6) as oxidimet-
ric titrants have been proposed. However, these require high
acidic conditions and the use of a screening indicator.4)
Methods based on the protonated nitrogen atom of the mole-
cules, including non-aqueous titration,7) two-phase titra-
tion,8,9) and titration with picrates of lead, copper, cadmium
and zinc,10) have also been used for the estimation of phe-
nothiazines. Non-aqueous titrimetry requires a scrupulously
anhydrous medium, which is inconvenient in practice,
whereas complexometric procedures10) involve the filteration
of the complex before titrating the unreacted metal, which is
cumbersome.
The determination of phenothiazines by spectrophotomet-
ric methods has been proposed based on oxidation with per-
sulphate,11) iron,12) chloramine-T,13) and N-bromosuccin-
imide14) to give products that can be determined either di-
rectly in the visible region or after coupling/condensing with
p-aminobenzoic acid,15) 3-methyl-2-benzothiazolinone hydra-
zone (MBTH),16) haematoxylin17) and morpholine.18) Other
chromogenic reactions use diphenylpicryl hydrazyl,19)
chlorophenolred,20) ammonium molybdate21) and nitroprus-
side.22) These methods involve a time-consuming extraction
step and require strictly controlled reaction conditions.
Phenothiazines in pharmaceutical preparations have been
determined by polarographic and potentiometric techniques.
The polarographic method is based on the prior conversion
of phenothiazines into polarographically active derivatives
through nitration,23) followed by measuring the redox wave.
Most of the potentiometric methods are based on the extrac-
tion of the free base, followed by titration with standard acids
in non-queous media.24) Other methods include stripping
voltammetry,25) HPLC26) and spectrofluorimetry27) but in-
volve expensive experimental setup.
The purpose of this investigation was to develop simple,
accurate, precise and inexpensive methods for the assay of
some phenothiazine psychotropics in pharmaceutical formu-
lations.
Experimental
A systronics model 106 Spectrophotometer with 1 cm pathlength quartz
cells was used for all absorbance measurements.
Reagents All reagents were of analytical-reagent grade and distilled
water was used for preparing all solutions.
Potassium Dichromate Solution (0.003 mol l21): Prepared by dissolving
0.8825 g potassium dichromate in 1000 ml of water. Suitable dilutions were
made to obtain a 10 mg ml21 chromium(IV) working standard solution for
spectrophotometry.
Ammonium Ferrous Sulphate (0.02 mol l21): This was prepared by dis-
solving about 3.92 g of the reagent in 50 ml of 2 mol l21 sulphuric acid and
diluting it to one litre with distilled water. The solution was then standard-
ized by a titration with standard solution of potassium dichromate using
diphenylamine sulphonic acid salt as an indicator.
Indicator (0.2%): Prepared by dissolving 0.2 g of barium salt of dipheny-
lamine sulphonic acid in 100 ml of distilled water.
s-Diphenylcarbazide (0.25%): Prepared by dissolving 0.25 g of reagent in
100 ml of acetone.
Sulphuric Acid (10 mol l21): Diluted 280 ml of concentrated sulphuric
acid (sp. gr. 1.84) to 500 ml with distilled water. It was further diluted to get
4 mol l21 for the spectrophotometric method.
Sample Solutions Pure drug samples were kindly provided by several
pharmaceutical companies and used as received. Stock standard solutions
containing 2000 mg ml21 drug were prepared by dissolving accurately
weighed 500 mg amounts of chlorpromazine hydrochloride, CPH (British
Pharm.); promethazine hydrochloride, PH (Rhone-Poulenc); prochlorper-
azine maleate, PCPM (SmithKline Beecham); triflupromazine hyrochloride,
TPH (Sarabhai Chemicals); trifluoperazine hydrochloride, TFPH (SmithK-
line Beecham) and thioproperzine mesylate, TPPM (Rhone-Poulenc) in dis-
tilled water in 250 ml calibrated flasks. A few drops of diluted hydrochloric
acid were used for dissolving PCPM. Each solution was further diluted step-
wise to get 40 mg ml21 of CPH, PH, TPH & TFPH and 80 mg ml21 of PCPM
and TPPM for spectrophotometric work.
Procedure Titrimetry: An aliquot (5 to 10 ml) containing 2—20 mg
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CPH, PH, TPH, or PCPM, 2—16 mg TFPH or TPPM was transferred to a
100 ml titration flask followed by the addition of 1 ml of 10 mol l21 sulphuric
acid and 10 ml of 0.003 mol l21 potassium dichromate. The reaction mixture
was shaken occasionally, and after a specified time (Table 1) the unreacted
dichromate was titrated with 0.02 mol l21 standardized ammonium ferrous
sulphate using 5 drops of barium salt of diphenylamine sulphonic acid indi-
cator. A reagent blank was run under identical conditions using all the
reagents except the drug.
Determination of Reacting Ratio and Minimum Reaction Time: A 5 ml
aliquot containing 2—16 mg of each drug was allowed to react with a known
excessive volume of potassium dichromate solution (0.003 mol l21). After
the complete disappearance of the orange or purple color, the unreacted oxi-
dant was back titrated. The reacting ratio (moles of dichromate per mole of
drug) was calculated for each test. The findings are presented in Table 1.
Spectrophotometry: In each of a series of 10 ml calibrated flasks was
placed 1 ml of 10 mg ml21 chromium(VI) solution followed by acidification
by the addition of 1 ml of 1 mol l21 sulphuric acid. After adding 0—2.5 ml of
CPH or TPH (40 mg ml21), 0—2.0 ml PH (40 mg ml21), 0—2.0 ml of PCPM
or TPPM (80 mg ml21) or 0—3.0 ml of TFPH (40 mg ml21), the overall aque-
ous volume was adjusted to 5 ml by the addition of requisite amount of dis-
tilled water, mixed well and allowed to stand for 20—30 min, i.e., until the
disappearance of the orange or purple color. Subsequently, 1 ml of 0.25% s-
diphenylcarbazide reagent was added, diluted to the mark with distilled
water, mixed well and absorbance was recorded at 540 nm against the dis-
tilled water blank. The concentration of the drug was calculated from the
calibration graph constructed under the same conditions or the regression
equation in each case.
Analysis of Pharmaceutical Preparations Tablets: Ten to forty tablets
depending on content per tablet were weighed and ground into a fine pow-
der. An amount of the powder equivalent to 100 mg of active component was
weighed into a 100 ml volumetric flask, about 60 ml of distilled water was
added and shaken thoroughly for about 20 min. The volume was increased to
the mark with distilled water, shaken and filtered using quantitative filter
paper. A 10 ml aliquot of this filtrate was analyzed by titrimetry. For spec-
trophotometric determination, the filtrate was diluted sequentially to get
40 mg ml21 in respect to CPH, PH, TPH and TFPH and 80 mg ml21 of drug
in the case of TPPM and PCPM. A suitable portion was then used for analy-
sis.
Injections: The contents of twenty ampoules were mixed and an accu-
rately measured volume equivalent to 100 mg of drug was transferred into a
100 ml calibrated flask and diluted to the mark with distilled water. Steps de-
scribed under the tablets were then followed. The samples were also ana-
lyzed by the official methods of British Pharmacopoeia and the results are
given in Table 3.
Results and Discussion
Titrimetry The method is based on the fact that dichro-
mate in an acidic medium directly oxidizes phenothiazines
first to purple or orange phenothiazonium free radicals and
finally to colorless sulphoxides.28) The effect of variables
such as oxidant concentration, strength of sulphuric acid,
temperature and reaction time were studied. It was found that
10 ml of 0.003 mol l21 solution of dichromate in 0.5 mol l21
sulphuric acid was suitable for a quantitative reaction. It was
also observed that the reaction was complete at room temper-
ature in 1—5 min depending on the amount of drug taken.
The number of moles of dichromate consumed per mole of
the drug was 0.333 in all cases, in conformity with the for-
mation of sulphoxides.28) Any delay up to 60 min in the back
titration of the unreacted dichromate did not result in the
consumption of more than a stoichiometric amount of
dichromate in the case of pure drugs, indicating that the oxi-
dation of drugs stopped at sulphoxide formation. However, in
the case of such formulations, especially tablets, when the
back titration of the unreacted dichromate was delayed be-
yond 15 min, more dichromate than the stoichiometric
amount was consumed. This is possibly due to the oxidation
of sugar which will be present in the tablets as an excipient.
Hence, in respect to formulations, it is recommended that the
unreacted dichromate be backtitrated immediately after the
decoloration of the radical cation. Other additives and excipi-
ents such as starch, talc, gelatin, alginate, stearate and
metabisulphite in levels found in formulations did not inter-
fere under the described experimental conditions. This is due
to the preferential reaction of phenothiazines with dichro-
mate and the self-indication system provided by the phenoth-
iazonium free radicals.
Spectrophotometry In an acid solution, s-diphenylcar-
bazide (1,5-diphenylcarbohydrazide) gives a soluble, strongly
colored red-violet product with hexavalent chromium.29) This
reaction has been the basis of the best method for the deter-
mination of the most minute amounts (0.2—1.0 mg ml21) of
chromium.30) In this work, known but excessive dichromate
was employed to oxidize phenothiazines in sulphuric acid
medium to colorless sulphoxides, and the unreacted dichro-
mate was determined by reacting it with s-diphenylcarbazide
in the same acidic condition. This formed the basis for the
determination of microquantities of phenothiazine drugs.
Phenothiazines, when added in increasing amounts, con-
sume dichromate; consequently there is a concomitant fall in
chromium(VI) concentration. This is observed as a propor-
tional decrease in the absorbance of the reaction mixture on
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Table 1. Analytical Data for the Titrimetric Determination of Phenothi-
azines
Drug
Reaction Molar ratio Range Recoverya) RSD
time (min) Drug : Oxidant (mg) (%) (%)
CPH 2 3 : 1 2—20 99.70 0.80
PH 2 3 : 1 2—20 99.30 1.01
PCPM 3 3 : 1 2—20 99.80 1.12
TPH 2 3 : 1 2—20 100.50 1.39
TFPH 3 3 : 1 2—16 100.20 1.31
TPPM 5 3 : 1 2—16 97.80 0.96
a) Average of six determinations each containing 10 mg of drug.
Fig. 1. Absorption Spectra Measured against Water
A, blank; B, 5 mg ml21 of CPH; C, without chromium(VI) solution.
increasing the concentration of phenothiazines.
The various parameters involved in the study were opti-
mized. Suitable acidity for the chromium(VI)–diphenylcar-
bazide reaction is 0.025—0.1 mol l21. At low acidities the
color does not develop immediately, but in 0.1 mol l21 H2SO4
solution, maximum color intensity is attained within a few
seconds. Solutions having an acidity of greater than
0.1 mol l21 are not desirable because the color is less stable in
these.31) In 0.1 mol l21 H2SO4, the color is quite stable
32)
(15 h). Although 0.1 mol l21 of sulphuric acid was adequate
for the reaction between chromium(VI) and s-diphenylcar-
bazide, a slightly higher concentration (0.4 mol l21) of sul-
phuric acid was employed in the present investigation to fa-
cilitate complete oxidation of phenothiazines to respective
sulphoxides in a reasonable time without affecting the sensi-
tivity and stability of the colored product. At acidities lower
than 0.4 mol l21, the reaction between drug and dichromate
was slow, taking more than 30 min. By employing higher
acidities (.0.4 mol l21), the reaction time and thereby the
analysis time could be reduced, but higher acidities are unde-
sirable since the reddish-violet product subsequently formed
between chromium(VI) and diphenylcarbazide is less stable
(less than 2 h).
Two blanks were prepared for this system. The reagent
blank, which contained optimum concentrations of all the
reagents except phenothiazines, gave maximum absorbance
(Fig. 1). The other blank was prepared in the absence of
dichromate to determine the contribution of other reagents to
the absorbance of the system. As the absorbance of this sec-
ond blank was comparable to that of water, the absorbance of
the developed color was measured against distilled water.
The developed color was stable for more than 1 h. The de-
creasing absorbance values at 540 nm were plotted against
increasing concentrations of phenothiazines to obtain the cal-
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Table 2. Optical Characteristics, Precision and Accuracy
Reaction Beer’s law Detection
Molar
Drug time limits limita)
absorptivity
Slope Intercept
Correlation RSDb)
(min) (mg ml21) (mg ml21) 310
4 co-efficient (%)
(l ·mol21 cm21)
CPH 20 0—9 0.013 1.772 20.0491 0.505 20.99 0.76
PH 20 0—8 0.068 1.774 20.0552 0.507 20.99 1.11
PCPM 30 0—16 0.045 1.781 20.0288 0.507 20.99 0.85
TPH 30 0—10 0.099 1.768 20.0450 0.507 20.99 0.46
TFPH 30 0—12 0.089 1.772 20.0376 0.510 21.00 1.32
TPPM 30 0—16 0.061 1.739 20.0275 0.512 20.99 0.64
a) CL53SB/m; CL, detection limit; SB, standard deviation of blank; m, slope of calibration. b) Average of seven determinations each containing 5 mg ml21 of CPH, PH, TPH
or TFPH and 8 mg ml21 of PCPM or TPPM.
Table 3. Assay of Phenothiazines in Pharmaceutical Preparation by Proposed and Reference Methods
Proposed methods
mg/tablet
Preparation or 
Titrimetry Spectrophotometry Reference Method t-valueb) F-valuec)
mg/ml
Found Recoverya) S.D. Found Recoverya) S.D. Found Recoverya) S.D. T S T S
(mg) (%) (mg) (%) (mg) (%)
CPH
Chloropromazine 100 99.9 99.90 0.82 99.2 99.2 0.58 99.5 99.5 0.63 0.91 0.81 1.69 1.17
tablet 25 24.89 99.56 0.37 25.51 102.0 0.50 25.42 101.7 0.50 1.82 0.30 2.01 1.00
Chlorpromazine 25 25.6 102.1 0.66 25.21 100.84 0.32 25.3 101.2 0.42 0.91 0.40 2.46 1.72
injection
PH
Phenergan tablet 10 10.02 100.2 0.63 10.04 100.4 0.42 10.01 100.1 0.82 0.002 0.05 1.69 3.81
Phenergan 25 24.77 99.1 0.35 25.30 101.2 0.26 25.21 100.84 0.54 2.07 0.37 2.38 4.33
injection
TPH
Siquil tablet 10 9.93 99.3 0.14 9.90 99.00 0.16 — — — — — — —
Siquil injection 10 9.99 9.99 0.17 9.92 99.2 0.32 — — — — — — —
TFPH
Neocalm 5 4.97 99.5 0.10 5.02 100.4 0.32 4.98 99.6 0.32 0.18 0.11 0.26 3.16
Trazine 5 4.96 99.2 0.15 5.01 100.2 0.46 4.99 99.8 0.20 0.23 0.08 3.48 2.69
PCPM
Stemitil injection 12.5 12.40 99.2 0.94 12.46 99.6 0.82 12.44 99.2 0.54 0.08 0.05 3.03 2.30
(As mesylate)
TPPM
Majeptil 5 4.93 98.6 0.92 4.95 99.0 0.65 — — — — — — —
a) Average of five determinations; b) Tabulated value 2.78; c) Tabulated value 6.39; T stands for titrimetry  and S for spectrophotometry. Recovery means recovery of active
component/content from the co-formulated substances.
ibration graphs. Beer’s law was obeyed over the concentra-
tion ranges given in Table 2. Correlation coefficients, inter-
cepts and slopes for the calibration data are also presented in
Table 2. The wide difference in the slopes of the calibration
curves of different phenothiazine drugs is due to the varying
molecular weights of the drugs, from 320.89 for PH to
638.86 for TPPM. The linear Beer’s law plots for the investi-
gated drugs can also be used to calculate concentrations. The
apparent molar absorptivities are around 1.773104
l ·mol21· cm21, and the detection limit33) is in the range of
0.013—0.099 mg ml21.
To examine the precision of the procedure, seven replicate
determinations were made on the same solution containing
5 mg ml21 of CPH, PH, TPH or TFPH and 8 mg ml21 of
PCPM or TPPM; coefficients of variation of 0.76, 1.11, 0.46,
1.32, 0.85 and 0.64, respectively, were obtained.
Among the concomitant substances, only glucose was
found to interfere with the determination. This could be
avoided by reacting the unreacted chromium(VI) with s-
diphenylcarbazide immediately after the disappearance of the
color due to a phenothiazonium radical, i.e., immediately
after the specified time (Table 2).
Application The proposed methods were applied to the
determination of studied drugs in their dosage forms. The re-
sults in Table 3 indicate that the methods give good accuracy
and precision, with satisfactory agreement with the results
obtained by the official method.
Statistical analysis of the results by F- and t-tests showed
no significant difference in accuracy and precision between
the proposed and official methods.
Conclusion
Although phenothiazines have been determined by a vari-
ety of techniques, the methods described here are simple,
highly sensitive (spectrophotometry), convenient and don’t
require special working conditions, unlike many other
reagents. Moreover, owing to the stability of the solid reagent
as well as aqueous solution, dichromate can be used for rou-
tine analysis.
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